Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non‐small cell lung cancer: A virtual randomized phase III trial stratified by age-Reference-Cited by-同舟云学术

Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non‐small cell lung cancer: A virtual randomized phase III trial stratified by age

Published:2019-05-23 Issue:6 Volume:10 Page:1489-1499
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Seo Young‐Seok¹²,Kim Hak Jae²³^ORCID,Wu Hong Gyun²³,Choi Sun Mi⁴,Park Samina⁵

Affiliation:

1. Department of Radiation Oncology ChungBuk National University Hospital Chungcheongbuk‐do Republic of Korea

2. Department of Radiation Oncology Seoul National University Hospital Seoul Republic of Korea

3. Department of Radiation Oncology Cancer Research Institute, Seoul National University College of Medicine Seoul Republic of Korea

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea

5. Department of Thoracic and Cardiovascular Surgery Seoul National University Hospital Seoul Republic of Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13103

Reference50 articles.

1. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer

2. Stereotactic Body Radiotherapy for Primary Lung Cancer at a Dose of 50 Gy Total in Five Fractions to the Periphery of the Planning Target Volume Calculated Using a Superposition Algorithm

3. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

4. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial

5. Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel nomogram to predict lymph node metastasis in cT1 non-small-cell lung cancer based on PET/CT and peripheral blood cell parameters;BMC Pulmonary Medicine;2023-01-30

2. Relapse predictability of topological signature on pretreatment planning CT images of stage I non‐small cell lung cancer patients before treatment with stereotactic ablative radiotherapy;Thoracic Cancer;2022-06-16

3. Comparative short-term outcomes of robotic-assisted surgery for older patients with non-small cell lung cancer: a propensity matched study;Updates in Surgery;2021-02-04

4. Bronchoscopic treatments for early‐stage peripheral lung cancer: Are we ready for prime time?;Respirology;2020-07-08

5. Robotic surgery can extend surgical indication in patients with lung cancer and impaired function;Journal of Thoracic Disease;2019-11